Fig. 4: NaB treatment increased GLP-1R protein levels in HepG2 cells with or without FFA treatment. | Experimental & Molecular Medicine

Fig. 4: NaB treatment increased GLP-1R protein levels in HepG2 cells with or without FFA treatment.

From: Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression

Fig. 4

a–d Western blot analysis of GLP-1R protein levels in HepG2 cells that were treated with increasing concentrations of FFA for 24 h (a), or in HepG2 cells that were treated with FFA for 0 to 48 h (b), or in HepG2 cells that were treated with NaB (c), or in HepG2 cells that were cotreated with FFA and NaB (d). e Triglyceride levels in HepG2 cells that were cotreated with FFA (0.5 mM) and NaB (1, 2, 5, or 10 mM). The data represent the means ± S.E.M.; vs. control *P < 0.05, **P < 0.01, and ***P < 0.001; vs. FFA ##P < 0.01 and ###P < 0.001

Back to article page